Scientists wanting to develop human disease models or screen new drugs can use iPS cell lines from patients with the disease background of interest to study the "disease in a dish". One big drawback of many human iPSC lines has been that the original donor consents did not allow them to be used by commercial scientists to do research on. EBiSC, the European Bank for iPS Cells was created to solve this problem and is now listing over 200 research grade human iPS cell lines from healthy controls and a growing range of disease backgrounds. Special areas of interest are the neurodegenerative diseases such as Parkinson's, Alzheimer's, Huntington's, FTD, ALS etc. https://cells.ebisc.org to search the EBiSC Collection for lines of interest.